Man-made Vascular Graft - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Man-made Vascular Graft was estimated to be worth US$ 4034 million in 2024 and is forecast to a readjusted size of US$ 5876 million by 2031 with a CAGR of 5.6% during the fore... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global market for Man-made Vascular Graft was estimated to be worth US$ 4034 million in 2024 and is forecast to a readjusted size of US$ 5876 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.Man-made Vascular Grafts are used to replace, bypass or maintain function of damaged, occluded or diseased blood vessels in small, medium and large diameter. Expanding Market Size With continuous advancements in medical technology and intensifying population aging, the market size for artificial blood vessels in China is also expanding steadily. It is estimated that the growth rate of the Chinese market will exceed the global average in the coming years. Technological Innovation Driving Market Development Application of New Materials: The field of artificial blood vessels is moving towards the direction of biodegradability, enhanced biocompatibility, and superior biomechanical properties. The application of biodegradable materials such as polylactic acid (PLA) and polycaprolactone (PCL) is expected to reduce the risks associated with long-term implantation in the body and improve patients' quality of life. The integration of nanotechnology has also brought new opportunities for enhancing the performance of artificial blood vessels. The application of nano-coatings and nano-fibers can enhance the blood vessels' antithrombotic capabilities, antibacterial properties, and durability, making artificial blood vessels safer and more reliable in clinical applications. Advancements in Bioprinting Technology: Bioprinting allows for the manufacturing of artificial blood vessels with complex structures and functions, better matching the physiological characteristics of human blood vessels, thus improving surgical success rates and patients' recovery speeds. Additionally, bioprinting technology enables the customization of artificial blood vessels to meet the diverse needs of different patients and surgical procedures. Intensifying Competition and Rising Market Concentration Competition Among Domestic and Foreign Enterprises: With the entrance of both domestic and foreign enterprises, competition in the artificial blood vessel market is becoming increasingly fierce. Companies need to continuously reduce costs to maintain their competitiveness while increasing investments in innovation and research and development to create differentiated advantages. Rising Market Concentration: The concentration of the Chinese artificial blood vessel market is relatively high, with major market participants occupying a significant market share. This concentration is reflected in diverse product lines, strong brand influence, and extensive market coverage. In the future, with intensifying market competition and industry consolidation, market concentration is expected to further increase. Policies and Health Insurance Support Promoting Market Development Policy Support: Government departments such as the National Development and Reform Commission have increased investments in medical services, promoting healthy capital flows for enterprises through policy support and accelerating industry development. Health Insurance Coverage: The improvement of the health insurance system has made artificial blood vessel treatments more affordable for more patients, further driving the growth of market demand. In the future, with the expansion of health insurance coverage and optimization of reimbursement policies, the demand for artificial blood vessels is expected to further increase. This report aims to provide a comprehensive presentation of the global market for Man-made Vascular Graft, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Man-made Vascular Graft by region & country, by Type, and by Application. The Man-made Vascular Graft market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Man-made Vascular Graft. Market Segmentation By Company Getinge Bard PV Terumo W. L. Gore Japan Lifeline B.Braun LeMaitre Vascular Shanghai Chest Medical Instruments Aortec Medical Technology JIANGSU BIODA LIFE SCIENCE Segment by Type ePTFE Man-made Vascular Graft Polyester Man-made Vascular Graft PTFE Man-made Vascular Graft Others Segment by Application Aortic Disease Peripheral Artery Disease Hemodialysis By Region North America United States Canada Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia-Pacific Europe Germany France U.K. Italy Netherlands Nordic Countries Rest of Europe Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA Chapter Outline Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 2: Detailed analysis of Man-made Vascular Graft manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Sales, revenue of Man-made Vascular Graft in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world. Chapter 6: Sales, revenue of Man-made Vascular Graft in country level. It provides sigmate data by Type, and by Application for each country/region. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 9: Conclusion. Table of Contents1 Market Overview1.1 Man-made Vascular Graft Product Introduction 1.2 Global Man-made Vascular Graft Market Size Forecast 1.2.1 Global Man-made Vascular Graft Sales Value (2020-2031) 1.2.2 Global Man-made Vascular Graft Sales Volume (2020-2031) 1.2.3 Global Man-made Vascular Graft Sales Price (2020-2031) 1.3 Man-made Vascular Graft Market Trends & Drivers 1.3.1 Man-made Vascular Graft Industry Trends 1.3.2 Man-made Vascular Graft Market Drivers & Opportunity 1.3.3 Man-made Vascular Graft Market Challenges 1.3.4 Man-made Vascular Graft Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Man-made Vascular Graft Players Revenue Ranking (2024) 2.2 Global Man-made Vascular Graft Revenue by Company (2020-2025) 2.3 Global Man-made Vascular Graft Players Sales Volume Ranking (2024) 2.4 Global Man-made Vascular Graft Sales Volume by Company Players (2020-2025) 2.5 Global Man-made Vascular Graft Average Price by Company (2020-2025) 2.6 Key Manufacturers Man-made Vascular Graft Manufacturing Base and Headquarters 2.7 Key Manufacturers Man-made Vascular Graft Product Offered 2.8 Key Manufacturers Time to Begin Mass Production of Man-made Vascular Graft 2.9 Man-made Vascular Graft Market Competitive Analysis 2.9.1 Man-made Vascular Graft Market Concentration Rate (2020-2025) 2.9.2 Global 5 and 10 Largest Manufacturers by Man-made Vascular Graft Revenue in 2024 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Man-made Vascular Graft as of 2024) 2.10 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 ePTFE Man-made Vascular Graft 3.1.2 Polyester Man-made Vascular Graft 3.1.3 PTFE Man-made Vascular Graft 3.1.4 Others 3.2 Global Man-made Vascular Graft Sales Value by Type 3.2.1 Global Man-made Vascular Graft Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Man-made Vascular Graft Sales Value, by Type (2020-2031) 3.2.3 Global Man-made Vascular Graft Sales Value, by Type (%) (2020-2031) 3.3 Global Man-made Vascular Graft Sales Volume by Type 3.3.1 Global Man-made Vascular Graft Sales Volume by Type (2020 VS 2024 VS 2031) 3.3.2 Global Man-made Vascular Graft Sales Volume, by Type (2020-2031) 3.3.3 Global Man-made Vascular Graft Sales Volume, by Type (%) (2020-2031) 3.4 Global Man-made Vascular Graft Average Price by Type (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Aortic Disease 4.1.2 Peripheral Artery Disease 4.1.3 Hemodialysis 4.2 Global Man-made Vascular Graft Sales Value by Application 4.2.1 Global Man-made Vascular Graft Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Man-made Vascular Graft Sales Value, by Application (2020-2031) 4.2.3 Global Man-made Vascular Graft Sales Value, by Application (%) (2020-2031) 4.3 Global Man-made Vascular Graft Sales Volume by Application 4.3.1 Global Man-made Vascular Graft Sales Volume by Application (2020 VS 2024 VS 2031) 4.3.2 Global Man-made Vascular Graft Sales Volume, by Application (2020-2031) 4.3.3 Global Man-made Vascular Graft Sales Volume, by Application (%) (2020-2031) 4.4 Global Man-made Vascular Graft Average Price by Application (2020-2031) 5 Segmentation by Region 5.1 Global Man-made Vascular Graft Sales Value by Region 5.1.1 Global Man-made Vascular Graft Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Man-made Vascular Graft Sales Value by Region (2020-2025) 5.1.3 Global Man-made Vascular Graft Sales Value by Region (2026-2031) 5.1.4 Global Man-made Vascular Graft Sales Value by Region (%), (2020-2031) 5.2 Global Man-made Vascular Graft Sales Volume by Region 5.2.1 Global Man-made Vascular Graft Sales Volume by Region: 2020 VS 2024 VS 2031 5.2.2 Global Man-made Vascular Graft Sales Volume by Region (2020-2025) 5.2.3 Global Man-made Vascular Graft Sales Volume by Region (2026-2031) 5.2.4 Global Man-made Vascular Graft Sales Volume by Region (%), (2020-2031) 5.3 Global Man-made Vascular Graft Average Price by Region (2020-2031) 5.4 North America 5.4.1 North America Man-made Vascular Graft Sales Value, 2020-2031 5.4.2 North America Man-made Vascular Graft Sales Value by Country (%), 2024 VS 2031 5.5 Europe 5.5.1 Europe Man-made Vascular Graft Sales Value, 2020-2031 5.5.2 Europe Man-made Vascular Graft Sales Value by Country (%), 2024 VS 2031 5.6 Asia Pacific 5.6.1 Asia Pacific Man-made Vascular Graft Sales Value, 2020-2031 5.6.2 Asia Pacific Man-made Vascular Graft Sales Value by Region (%), 2024 VS 2031 5.7 South America 5.7.1 South America Man-made Vascular Graft Sales Value, 2020-2031 5.7.2 South America Man-made Vascular Graft Sales Value by Country (%), 2024 VS 2031 5.8 Middle East & Africa 5.8.1 Middle East & Africa Man-made Vascular Graft Sales Value, 2020-2031 5.8.2 Middle East & Africa Man-made Vascular Graft Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Man-made Vascular Graft Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Man-made Vascular Graft Sales Value and Sales Volume 6.2.1 Key Countries/Regions Man-made Vascular Graft Sales Value, 2020-2031 6.2.2 Key Countries/Regions Man-made Vascular Graft Sales Volume, 2020-2031 6.3 United States 6.3.1 United States Man-made Vascular Graft Sales Value, 2020-2031 6.3.2 United States Man-made Vascular Graft Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Man-made Vascular Graft Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Man-made Vascular Graft Sales Value, 2020-2031 6.4.2 Europe Man-made Vascular Graft Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Man-made Vascular Graft Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Man-made Vascular Graft Sales Value, 2020-2031 6.5.2 China Man-made Vascular Graft Sales Value by Type (%), 2024 VS 2031 6.5.3 China Man-made Vascular Graft Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Man-made Vascular Graft Sales Value, 2020-2031 6.6.2 Japan Man-made Vascular Graft Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Man-made Vascular Graft Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Man-made Vascular Graft Sales Value, 2020-2031 6.7.2 South Korea Man-made Vascular Graft Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Man-made Vascular Graft Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Man-made Vascular Graft Sales Value, 2020-2031 6.8.2 Southeast Asia Man-made Vascular Graft Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Man-made Vascular Graft Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Man-made Vascular Graft Sales Value, 2020-2031 6.9.2 India Man-made Vascular Graft Sales Value by Type (%), 2024 VS 2031 6.9.3 India Man-made Vascular Graft Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 Getinge 7.1.1 Getinge Company Information 7.1.2 Getinge Introduction and Business Overview 7.1.3 Getinge Man-made Vascular Graft Sales, Revenue, Price and Gross Margin (2020-2025) 7.1.4 Getinge Man-made Vascular Graft Product Offerings 7.1.5 Getinge Recent Development 7.2 Bard PV 7.2.1 Bard PV Company Information 7.2.2 Bard PV Introduction and Business Overview 7.2.3 Bard PV Man-made Vascular Graft Sales, Revenue, Price and Gross Margin (2020-2025) 7.2.4 Bard PV Man-made Vascular Graft Product Offerings 7.2.5 Bard PV Recent Development 7.3 Terumo 7.3.1 Terumo Company Information 7.3.2 Terumo Introduction and Business Overview 7.3.3 Terumo Man-made Vascular Graft Sales, Revenue, Price and Gross Margin (2020-2025) 7.3.4 Terumo Man-made Vascular Graft Product Offerings 7.3.5 Terumo Recent Development 7.4 W. L. Gore 7.4.1 W. L. Gore Company Information 7.4.2 W. L. Gore Introduction and Business Overview 7.4.3 W. L. Gore Man-made Vascular Graft Sales, Revenue, Price and Gross Margin (2020-2025) 7.4.4 W. L. Gore Man-made Vascular Graft Product Offerings 7.4.5 W. L. Gore Recent Development 7.5 Japan Lifeline 7.5.1 Japan Lifeline Company Information 7.5.2 Japan Lifeline Introduction and Business Overview 7.5.3 Japan Lifeline Man-made Vascular Graft Sales, Revenue, Price and Gross Margin (2020-2025) 7.5.4 Japan Lifeline Man-made Vascular Graft Product Offerings 7.5.5 Japan Lifeline Recent Development 7.6 B.Braun 7.6.1 B.Braun Company Information 7.6.2 B.Braun Introduction and Business Overview 7.6.3 B.Braun Man-made Vascular Graft Sales, Revenue, Price and Gross Margin (2020-2025) 7.6.4 B.Braun Man-made Vascular Graft Product Offerings 7.6.5 B.Braun Recent Development 7.7 LeMaitre Vascular 7.7.1 LeMaitre Vascular Company Information 7.7.2 LeMaitre Vascular Introduction and Business Overview 7.7.3 LeMaitre Vascular Man-made Vascular Graft Sales, Revenue, Price and Gross Margin (2020-2025) 7.7.4 LeMaitre Vascular Man-made Vascular Graft Product Offerings 7.7.5 LeMaitre Vascular Recent Development 7.8 Shanghai Chest Medical Instruments 7.8.1 Shanghai Chest Medical Instruments Company Information 7.8.2 Shanghai Chest Medical Instruments Introduction and Business Overview 7.8.3 Shanghai Chest Medical Instruments Man-made Vascular Graft Sales, Revenue, Price and Gross Margin (2020-2025) 7.8.4 Shanghai Chest Medical Instruments Man-made Vascular Graft Product Offerings 7.8.5 Shanghai Chest Medical Instruments Recent Development 7.9 Aortec Medical Technology 7.9.1 Aortec Medical Technology Company Information 7.9.2 Aortec Medical Technology Introduction and Business Overview 7.9.3 Aortec Medical Technology Man-made Vascular Graft Sales, Revenue, Price and Gross Margin (2020-2025) 7.9.4 Aortec Medical Technology Man-made Vascular Graft Product Offerings 7.9.5 Aortec Medical Technology Recent Development 7.10 JIANGSU BIODA LIFE SCIENCE 7.10.1 JIANGSU BIODA LIFE SCIENCE Company Information 7.10.2 JIANGSU BIODA LIFE SCIENCE Introduction and Business Overview 7.10.3 JIANGSU BIODA LIFE SCIENCE Man-made Vascular Graft Sales, Revenue, Price and Gross Margin (2020-2025) 7.10.4 JIANGSU BIODA LIFE SCIENCE Man-made Vascular Graft Product Offerings 7.10.5 JIANGSU BIODA LIFE SCIENCE Recent Development 8 Industry Chain Analysis 8.1 Man-made Vascular Graft Industrial Chain 8.2 Man-made Vascular Graft Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Man-made Vascular Graft Sales Model 8.5.2 Sales Channel 8.5.3 Man-made Vascular Graft Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療/ヘルスケア)の最新刊レポート
QYResearch社の 医薬・ヘルスケア分野 での最新刊レポート
本レポートと同じKEY WORD(vascular)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|